Global Antihistamines Market, 2018-2026 - Market is Expected to Grow at a CAGR of 8.7% - ResearchAndMarkets.com

September 24, 2018
The “Global Antihistamines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026” report has been added to ResearchAndMarkets.com’s offering. The global antihistamines market is expected to grow at a CAGR of 8.7% during the forecast period from 2018 to 2026 Histamine is a key intermediary of instant hypersensitivity reactions acting locally and assisting vasodilation, smooth muscle contraction, high vascular permeability, inflammation, and edema. Antihistamines are representative of a class of drugs that inhibit the histamine type 1 (H1) receptors. H1 receptor is present on smooth muscle of bronchi, gastrointestinal tract, uterus, and large blood vessels. The major application of antihistamines has been observed in treatment of symptoms such as allergic conditions including itching, runny nose, nasal stuffiness, urticaria, teary eyes, dizziness, cough, and nausea. A few common side effects observed due to antihistamines treatment are sedation, impaired motor function, dry mouth & throat, dizziness, blurred vision, constipation and urinary retention. However, since a few decades modern drug development technologies have helped to reduce aforementioned side effects of antihistamines.The two classes of antihistamines comprise first generation and second generation antihistamines. The first generation antihistamines comprises of drugs such as alimemazine, clemastine, chlorphenamine, hydroxyzine, cyproheptadine, ketotifen, promethazine and others. The drugs such as cetirizine, acrivastine, desloratadine, levocetirizine, fexofenadine, and loratadine. In 2017, second generation antihistamines segment was observed as the largest market as they are used as first line of action in diseases such as urticaria & common cold, and modern drug development technologies have assisted to enhance the activity of second generation antihistamines e.g.: Levocitirizine was developed from cetirizine to reduce dizziness caused by cetirizine. Thus, technological support is expected to develop the therapeutic effect of second generation antihistamines in the near future. Key players in the market include Bayer AG, Almirall S.A., Johnson & Johnson, AstraZeneca plc, Novartis AG, Pfizer, Inc., Sanofi SA, Boehringer Ingelheim GmbH, Merck & Co., Inc., Akorn, Inc., Teva Pharmaceutical Industries Ltd., and others.

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Antihistamines: Market Dynamics and Outlook

Chapter 4. Global Antihistamines Market, by Antihistamines Type, 2016-2026 (US$ Mn)

Chapter 5. Global Antihistamines Market, by Application, 2016-2026 (US$ Mn)

Chapter 6. Global Antihistamines Market, by Geography, 2016-2026 (US$ Mn)

Chapter 7. Profiles

Bayer AGAlmirall S.A.Johnson & JohnsonAstraZeneca plcNovartis AGPfizer, Inc.Sanofi SABoehringer Ingelheim GmbHMerck & Co., Inc.Akorn, Inc.Teva Pharmaceutical Industries Ltd.Celgene CorporationF. Hoffman-La RocheFor more information about this report visit https://www.researchandmarkets.com/research/n6v6z5/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180924005478/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Over the Counter (OTC) Drugs,Allergy Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/24/2018 08:02 AM/DISC: 09/24/2018 08:02 AM


Update hourly